Brokerages Set Simulations Plus, Inc. (NASDAQ:SLP) Target Price at $24.40

Simulations Plus, Inc. (NASDAQ:SLP) has received an average recommendation of “Hold” from the ten analysts that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $24.40.

Several equities analysts have commented on SLP shares. Wall Street Zen upgraded shares of Simulations Plus from a “hold” rating to a “buy” rating in a report on Saturday, May 16th. Zacks Research cut shares of Simulations Plus from a “strong-buy” rating to a “hold” rating in a research report on Monday, February 2nd. TD Cowen reduced their target price on shares of Simulations Plus from $19.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 10th. Finally, Weiss Ratings cut shares of Simulations Plus from a “sell (d)” rating to a “sell (d-)” rating in a research report on Thursday, May 21st.

Institutional Investors Weigh In On Simulations Plus

A number of institutional investors have recently modified their holdings of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Simulations Plus by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company’s stock worth $233,000 after purchasing an additional 390 shares during the period. Bank of New York Mellon Corp lifted its position in Simulations Plus by 1.3% during the first quarter. Bank of New York Mellon Corp now owns 63,592 shares of the technology company’s stock worth $752,000 after purchasing an additional 844 shares during the period. Deutsche Bank AG lifted its position in Simulations Plus by 5.9% during the fourth quarter. Deutsche Bank AG now owns 15,825 shares of the technology company’s stock worth $288,000 after purchasing an additional 875 shares during the period. Prudential Financial Inc. lifted its position in Simulations Plus by 5.7% during the second quarter. Prudential Financial Inc. now owns 17,213 shares of the technology company’s stock worth $300,000 after purchasing an additional 930 shares during the period. Finally, Invesco Ltd. lifted its position in Simulations Plus by 3.8% during the second quarter. Invesco Ltd. now owns 36,452 shares of the technology company’s stock worth $636,000 after purchasing an additional 1,323 shares during the period. Institutional investors own 78.08% of the company’s stock.

Simulations Plus Price Performance

NASDAQ:SLP opened at $15.28 on Friday. Simulations Plus has a one year low of $11.09 and a one year high of $34.01. The company has a market cap of $308.66 million, a P/E ratio of -4.88 and a beta of 1.28. The firm’s fifty day moving average price is $13.57 and its two-hundred day moving average price is $15.62.

Simulations Plus (NASDAQ:SLP) last released its quarterly earnings data on Thursday, April 9th. The technology company reported $0.35 EPS for the quarter, beating the consensus estimate of $0.27 by $0.08. Simulations Plus had a negative net margin of 77.96% and a positive return on equity of 16.21%. The firm had revenue of $24.29 million for the quarter, compared to the consensus estimate of $21.66 million. As a group, equities research analysts expect that Simulations Plus will post 0.85 earnings per share for the current year.

Simulations Plus Company Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.